Active Filter(s):
Details:
Novasep has successfully optimized and scaled-up the process of Adcitmer® (monomethyl auristatin E-conjugated antibody), McSAF Inside® Oncology’s first-in-class proprietary ADC to treat neuroendocrine cancers.
Lead Product(s): Monomethyl Auristatin E-Conjugated Antibody
Therapeutic Area: Oncology Product Name: Adcitmer
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: Axplora
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration November 18, 2021